Komori
Occurring Fact2667ImageONE Co.,Ltd.Trading & Wholesale

Notice regarding the recognition of non-operating expenses and extraordinary loss (loss on valuation of investment securities)

During the cumulative fourth quarter of the fiscal year ended September 2026, the company recorded a loss on management of an investment partnership of ¥56.588 million and an allowance for doubtful accounts of ¥125.000 million relating to loans to Kaihan Medical as non-operating expenses. In addition, it recorded a ¥9.999 million loss on the valuation of its investment securities as an extraordinary loss.

Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
125000
Thousand yen (allowance for doubtful accounts; separately, a loss on management of an investment partnership of ¥56,588 thousand and a loss on valuation of investment securities of ¥9,999 thousand)
Wording
Definitive
How definitive the wording is.

Recognition of non-operating expenses and extraordinary loss (loss on valuation of investment securities)

Subject Entity

IMAGE ONE CO., LTD. (filing company)

Target Locations / Products

アリスタゴラVCイスラエル・テクノロジーL.P., loans to Kaihan Medical, and investment securities held by the company

OccurrenceCumulative fourth quarter of the fiscal year ended September 2026 (the loss on valuation of investment securities relates to the consolidated fourth-quarter accounting period of the fiscal year ended September 2026)
This disclosure11/12/2026
Cause

Fluctuations in the valuation of assets held by the investment partnership; a conservative assessment of the recoverability of loans based on Kaihan Medical’s financial condition, operating results, cash flow and ability to secure funds for repayment; and a significant decline in the valuation of the investment securities held, leading to the determination that short-term recovery would be difficult

Amount of Impact on Business Performance

Loss on management of an investment partnership: ¥56.588 million (non-operating expense); allowance for doubtful accounts: ¥125.000 million (non-operating expense); loss on valuation of investment securities: ¥9.999 million (extraordinary loss)

Accounting period in which recognized

The loss on management of the investment partnership and the allowance for doubtful accounts relate to the cumulative fourth quarter of the fiscal year ended September 2026; the loss on valuation of investment securities relates to the consolidated fourth-quarter accounting period of the fiscal year ended September 2026

Impact on Earnings Forecast

This document does not state the impact on the earnings forecast or the figures after revision. It refers to the notice of revision to the full-year earnings forecast dated 12 August 2026.

Amount of receivables at risk of non-collection or delayed collection

¥125.000 million (loans to Kaihan Medical)

Event that occurred
ItemDetails
Event nameRecognition of non-operating expenses and extraordinary loss (loss on valuation of investment securities)
Date of occurrenceCumulative fourth quarter of the fiscal year ended September 2026 (the loss on valuation of investment securities relates to the consolidated fourth-quarter accounting period of the fiscal year ended September 2026)
Subject EntityIMAGE ONE CO., LTD. (filing company)
Target Locations / ProductsアリスタゴラVCイスラエル・テクノロジーL.P., loans to Kaihan Medical, and investment securities held by the company
CauseFluctuations in the valuation of assets held by the investment partnership; a conservative assessment of the recoverability of loans based on Kaihan Medical’s financial condition, operating results, cash flow and ability to secure funds for repayment; and a significant decline in the valuation of the investment securities held, leading to the determination that short-term recovery would be difficult
Amount of Impact on Business PerformanceLoss on management of an investment partnership: ¥56.588 million (non-operating expense); allowance for doubtful accounts: ¥125.000 million (non-operating expense); loss on valuation of investment securities: ¥9.999 million (extraordinary loss)
Accounting period in which recognizedThe loss on management of the investment partnership and the allowance for doubtful accounts relate to the cumulative fourth quarter of the fiscal year ended September 2026; the loss on valuation of investment securities relates to the consolidated fourth-quarter accounting period of the fiscal year ended September 2026
Impact on Earnings ForecastThis document does not state the impact on the earnings forecast or the figures after revision. It refers to the notice of revision to the full-year earnings forecast dated 12 August 2026.
Amount of receivables at risk of non-collection or delayed collection¥125.000 million (loans to Kaihan Medical)
Items this document does not state (16)
Date recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changeOutlookPlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The valuation of assets held by the investment partnership fluctuated; the recoverability of the loans was assessed conservatively in light of Kaihan Medical’s financial condition, operating results, cash flow and ability to secure funds for repayment; and the valuation of the investment securities held declined significantly from their acquisition cost, leading the company to determine that short-term recovery would be difficult.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice regarding the recognition of non-operating expenses and extraordinary loss (loss on valuation of investment securities) | ImageONE Co.,Ltd. (2667) timely disclosure | Komori